1.	ß-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: SHEBA-09-6994-OZ-CTIL, NCT00888797
2.	Study of Sorafenib With or Without VT-122 in Patients With Hepatocellular Carcinoma (HCC) Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: VT1-CAX-200, NCT01265576
3.	Perioperative Administration of COX 2 Inhibitors and Beta Blockers to Women Undergoing Breast Cancer Surgery: an Intervention to Decrease Immune Suppression, Metastatic Potential and Cancer Recurrence Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 20 to 75 Sponsor: Other Protocol IDs: 392-22.6.07 / 2358, NCT00502684